Yes, ordering "complement C3+C4" is the same as ordering C3 and C4 separately
Ordering a complement panel that includes C3 and C4 together is functionally equivalent to ordering these tests separately—both provide the same quantitative measurements of these individual complement components. The difference is purely administrative (how the lab processes the order) rather than clinical.
What You're Actually Getting
When you order complement testing, whether bundled or separate, you receive:
- C3 level: A quantitative measurement of complement component 3 in g/L or mg/dL
- C4 level: A quantitative measurement of complement component 4 in g/L or mg/dL
These are individual component measurements, not functional assays. The guideline evidence 1 consistently references measuring "levels of factor B and C4" or "levels of C3 and other components" as separate quantitative values used to assess complement consumption and pathway activation.
Key Clinical Distinctions
What C3 and C4 levels tell you:
- Both low: Suggests complement consumption (active disease process) 1
- C4 low, C3 normal: Consider hereditary angioedema (check C1 inhibitor) 1
- C3 low, C4 normal: Possible alternative pathway defect or regulatory component deficiency 1
What C3 and C4 levels DON'T tell you:
These quantitative measurements are not the same as functional complement assays (CH50 or AH50). The guidelines 1 clearly distinguish between:
- Component levels (C3, C4) - what you're ordering
- Functional assays (CH50, AH50) - which test pathway activity
Important Caveats
Specimen handling matters more than how you order: Complement components are unstable and degrade with time, especially if warmed. For accurate measurements, blood specimens should be placed on ice or refrigerated immediately after drawing 1. This is critical regardless of whether you order tests together or separately.
Avoid redundant testing: Research shows that 77% of patients had multiple complement assays ordered, with results being discordant in only 24% of cases 2. When screening is appropriate, consider ordering a single C3 assay initially rather than multiple assays, unless you specifically suspect hereditary complement deficiency or need to differentiate pathway involvement 2.
Clinical context determines utility: For suspected rheumatic disease screening, complement testing has poor diagnostic value—all patients eventually diagnosed with rheumatic disease had normal complement levels in one study 2. Reserve complement testing for specific indications like suspected complement deficiency, glomerulonephritis, or monitoring known complement-mediated disease.